{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:46:37Z","timestamp":1793339197935,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,11,19]]},"DOI":"10.1001\/jama.2019.17380","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T14:00:38Z","timestamp":1573221638000},"page":"1899","source":"Crossref","is-referenced-by-count":119,"title":["Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes"],"prefix":"10.1001","volume":"322","author":[{"given":"Ian H.","family":"de Boer","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle"},{"name":"Kidney Research Institute, University of Washington, Seattle"},{"name":"Puget Sound VA Healthcare System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila R.","family":"Zelnick","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle"},{"name":"Kidney Research Institute, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ruzinski","sequence":"additional","affiliation":[{"name":"Kidney Research Institute, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Friedenberg","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Duszlak","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim Y.","family":"Bubes","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Hoofnagle","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle"},{"name":"Department of Laboratory Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thadhani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Buring","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Sesso","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"joi190122r1","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA consensus conference.","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"issue":"24","key":"joi190122r2","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States.","volume":"305","author":"de Boer","year":"2011","journal-title":"JAMA"},{"issue":"12","key":"joi190122r3","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2215\/CJN.03700417","article-title":"Diabetes and CKD in the United States population, 2009-2014.","volume":"12","author":"Zelnick","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"joi190122r4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014.","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"joi190122r5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes.","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"joi190122r6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cct.2018.09.014","article-title":"Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: rationale, design, and baseline characteristics.","volume":"74","author":"de Boer","year":"2018","journal-title":"Contemp Clin Trials"},{"issue":"41","key":"joi190122r7","doi-asserted-by":"publisher","first-page":"15896","DOI":"10.1073\/pnas.0803751105","article-title":"Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"joi190122r8","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1172\/JCI67804","article-title":"A nonclassical vitamin D receptor pathway suppresses renal fibrosis.","volume":"123","author":"Ito","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"joi190122r9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrneph.2010.156","article-title":"Effects of polyunsaturated fatty acid consumption in diabetic nephropathy.","volume":"7","author":"Shapiro","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"joi190122r10","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2215\/CJN.02640311","article-title":"Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate.","volume":"6","author":"de Boer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"joi190122r11","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1210\/jc.2012-2852","article-title":"Circulating vitamin D metabolites and kidney disease in type 1 diabetes.","volume":"97","author":"de Boer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"joi190122r12","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3945\/ajcn.2008.26867","article-title":"The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials.","volume":"89","author":"Miller","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"joi190122r13","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2215\/CJN.10441013","article-title":"Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.","volume":"9","author":"Hoogeveen","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"joi190122r14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004740","article-title":"Eicosapentaenoic and docosahexaenoic acids attenuate progression of albuminuria in patients with type 2 diabetes mellitus and coronary artery disease.","volume":"6","author":"Elajami","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"joi190122r15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.15171\/jnp.2017.03","article-title":"Effect of vitamin D on proteinuria in type 2 diabetic patients.","volume":"6","author":"Momeni","year":"2017","journal-title":"J Nephropathol"},{"issue":"1","key":"joi190122r16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The Vitamin D and Omega-3 Trial (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"},{"issue":"6","key":"joi190122r17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"joi190122r18","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1681\/ASN.2014040396","article-title":"Assessing the validity of surrogate outcomes for ESRD: a meta-analysis.","volume":"26","author":"Jun","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"joi190122r19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"joi190122r20","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2019010007","article-title":"GFR slope as a surrogate end point for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomized controlled trials.","volume":"30","author":"Inker","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"joi190122r21","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1681\/ASN.2019010009","article-title":"Performance of GFR slope as a surrogate end point for kidney disease progression in clinical trials: a statistical simulation.","volume":"30","author":"Greene","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"joi190122r23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease.","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"joi190122r24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and cancer.","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"issue":"24","key":"joi190122r25","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"joi190122r26","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin D treatment for reduction of residual proteinuria: a systematic review.","volume":"24","author":"de Borst","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"joi190122r27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ki.2011.224","article-title":"Oral cholecalciferol decreases albuminuria and urinary TGF-\u00df1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition.","volume":"80","author":"Kim","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"joi190122r28","first-page":"374","article-title":"Whether vitamin D3 is effective in reducing proteinuria in type 2 diabetic patients?","volume":"18","author":"Ahmadi","year":"2013","journal-title":"J Res Med Sci"},{"key":"joi190122r22","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2755300\/jama_de_boer_2019_oi_190122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T12:52:33Z","timestamp":1591188753000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2755300"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":28,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,11,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.17380","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736875953.793568166","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,19]]}}}